Outcomes of patients admitted with malignant small bowel obstruction: a subgroup multicentre observational cohort analysis

• Published in: Langenbeck's archives of surgery 2024-08, Vol.409 (1), p.239, Article 239
• Main Authors: Hupfeld, N. B., Burcharth, J., Jensen, T. K., Lolle, I., Nielsen, L. B. J., Tolver, M. A., Skovsen, A. P., Smith, H. G.
• Format: Article
• Language: English
• Subjects: Abdominal Surgery; Adult; Aged; Aged, 80 and over; Cardiac Surgery; Cohort Studies; Female; General Surgery; Humans; Intestinal Neoplasms - complications; Intestinal Neoplasms - mortality; Intestinal Neoplasms - pathology; Intestinal Neoplasms - surgery; Intestinal Obstruction - etiology; Intestinal Obstruction - mortality; Intestinal Obstruction - surgery; Intestine, Small - pathology; Male; Medicine; Medicine & Public Health; Middle Aged; Palliative Care; Survival Rate; Thoracic Surgery; Traumatic Surgery; Treatment Outcome; Vascular Surgery
• ISSN: 1435-2451; 1435-2443; 1435-2451
• DOI: 10.1007/s00423-024-03436-3

Introduction and purpose of the study Small bowel obstruction (SBO) accounts for a substantial proportion of emergency surgical admissions. Malignancy is a common cause of obstruction, either due to a primary tumour or intra-abdominal metastases. However, little is known regarding the current treatment or outcomes of patients with malignant SBO. This study aimed to characterise the treatment of malignant SBO and identify areas for potential improvement and compare overall survival of patients with malignant SBO to patients with non-malignant SBO. Materials and methods This was a subgroup analysis of a multicentre observational study of patients admitted with SBO. Details regarding these patients’ diagnoses, treatments, and outcomes up to 1-year after admission were recorded. The primary outcome was overall survival in patients with malignant SBO. Results A total of 316 patients with small bowel obstruction were included, of whom 33 (10.4%) had malignant SBO. Out of the 33 patients with malignant SBO, 20 patients (60.6%) were treated with palliative intent although only 7 patients were seen by a palliative team during admission. Nutritional assessments were performed on 12 patients, and 11 of these patients received parenteral nutrition. 23 patients underwent surgery, with the most common surgical interventions being loop ileostomies (9 patients) and gastrointestinal bypasses (9 patients). 4 patients underwent right hemicolectomies, with a primary anastomosis formed and 1 patient had a right hemicolectomy with a terminal ileostomy. Median survival was 114 days, and no difference was seen in survival between patients treated with or without palliative intent. Conclusion Malignant SBO is associated with significant risks of short-term complications and a poor prognosis. Consideration should be given to the early involvement of senior decision-makers upon patient admission is essential for optimal management and setting expectation for a realistic outcome.